EcoDrugPlus

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSOPRG00000010851
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOPRG00000007434
Gene Symbol: GSK3B
1 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSOPRG00000007980
Gene Symbol: GNRHR
1 Cross references
454 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSOPRG00000006538
Gene Symbol: GHRHR
3 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSOPRG00000003254
Gene Symbol: GHSR
2 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSOPRG00000000845
Gene Symbol: GUCY1A1
1 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSOPRG00000010867
Gene Symbol: GUCY1A2
1 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSOPRG00000013754
Gene Symbol: GUCY1B1
1 Cross references
209 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSOPRG00000003507
Gene Symbol: HMGB1
1 Cross references
225 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSOPRG00000014794
Gene Symbol: HRH4
3 Cross references
105 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSOPRG00000000851
Gene Symbol: HDAC1
1 Cross references
266 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSOPRG00000010361
Gene Symbol: HDAC11
3 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).